We found 7 drugmaker programs for Myasthenia Gravis medicines and 6 charity funds (3 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Myasthenia Gravis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Medical and medication costs.
Covers: Insurance premiums and copays.
Covers: Out-of-pocket costs for approved medications. Up to $10,000 a year.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays for FDA-approved medications (plus travel for some funds).
Covers: Meal delivery for food-insecure MG households.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Eligible commercially insured patients pay as little as $0 per infusion. Covers the drug and some infusion and monitoring costs; yearly maximum. No government insurance.
Treatment Administration Cost Support helps with certain infusion administration and related monitoring costs for eligible commercially insured patients.
IMAAVY withMe Access Program: for eligible commercial patients whose coverage is delayed more than 5 business days or denied.
Uninsured patients, or those whose insurance does not fully meet their needs, may get the medicine free for up to one year if they meet income and eligibility rules.
Free-drug terms at PatientAssistanceInfo.com/IMM.
Commercially insured patients may pay as little as $0 per dose. Medicare, Medicaid, TRICARE, VA and other government plans excluded.
Copay program terms include support for administration costs, except for residents of Massachusetts, Minnesota and Rhode Island.
Rystiggo Patient Assistance Program: eligible patients may get Rystiggo at no cost for up to 12 months. Contact ONWARD for criteria.
Dedicated Care Coordinator reviews coverage and financial options, even if uninsured; infusion finder.
Phone is 1-844-ONWARD-1. Free-drug eligibility criteria not listed on the page.
Eligible commercially insured patients may pay as little as $0 for SOLIRIS. Must enroll in OneSource. Not for Medicare, Medicaid or other government insurance.
OneSource provides help navigating health insurance, treatment education, and a local Patient Education Manager.
If you have Medicare, Medicaid or other government insurance, OneSource says it can connect you to third-party resources that may help. The Soliris copay program may also help with some infusion costs.
Eligible commercially insured patients may pay as little as $0 for ULTOMIRIS. Must enroll in OneSource. Not for Medicare, Medicaid or other government insurance.
OneSource provides help navigating health insurance, treatment education, and a local Patient Education Manager.
If you have Medicare, Medicaid or other government insurance, OneSource says it can connect you to third-party resources that may help. OneSource also offers vaccination support.
Eligible commercially insured patients may pay as little as $0 for UPLIZNA and infusion costs through the Amgen Commercial Co-Pay Program. Not for government insurance.
The co-pay program can help with infusion (administration) costs. Residents of Massachusetts or Rhode Island are not eligible for administration support.
A dedicated Patient Access Liaison helps with insurance approval, prior authorization and scheduling infusions.
Official UPLIZNA pages do not describe a free drug program, and UPLIZNA was not on the Amgen Safety Net Foundation product list. Ask Amgen By Your Side about options if uninsured.
Eligible commercially insured patients may pay as little as $0 for VYVGART and its administration, up to $25,000 per calendar year.
The copay program also covers eligible out-of-pocket costs for drug administration. Massachusetts and Rhode Island residents do not qualify for administration-cost help.
Quick Start Program gives eligible new patients VYVGART Hytrulo at no cost for a limited time if commercial insurance delays access. Must be enrolled in My VYVGART Path.
A Nurse Case Manager, with access and financial assistance specialists, helps with insurance, benefits review and checking eligibility for financial help.
The Quick Start Program covers VYVGART Hytrulo only, not the IV form. mypathenroll.com is argenx's online enrollment portal, not a program information page.
Commercially insured patients may pay as little as $0. Medicare, Medicaid, TRICARE, VA and other government plans excluded.
Zilbrysq Patient Assistance Program: patients meeting financial criteria may get Zilbrysq at no cost for up to 12 months.
Dedicated Care Coordinator reviews coverage and financial options, even if uninsured; injection coaching.
Phone is 1-844-ONWARD-1.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 7 drugmaker programs for Myasthenia Gravis medicines and 6 charity funds, 3 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Myasthenia Gravis, 1 charity fund on this page accepts Medicare (1 open at our last check), and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, NORD RareCare's Myasthenia Gravis Medical Assistance fund, NORD RareCare's Myasthenia Gravis Premium Copay Assistance fund, TotalAssist's Myasthenia Gravis fund were open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Myasthenia Gravis medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (NORD RareCare, TotalAssist, The Assistance Fund, Good Days, Myasthenia Gravis Foundation of America) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
